| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Transformation, Neoplastic | 5 | 2011 | 196 | 0.720 |
Why?
|
| Mitogen-Activated Protein Kinases | 7 | 2004 | 201 | 0.590 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 9 | 2018 | 123 | 0.460 |
Why?
|
| Diet, High-Fat | 4 | 2019 | 159 | 0.440 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2018 | 419 | 0.420 |
Why?
|
| ras Proteins | 2 | 2003 | 78 | 0.410 |
Why?
|
| Hepatocytes | 4 | 2022 | 195 | 0.380 |
Why?
|
| Signal Transduction | 11 | 2019 | 2892 | 0.370 |
Why?
|
| Liver | 4 | 2022 | 788 | 0.360 |
Why?
|
| PPAR alpha | 2 | 2022 | 29 | 0.340 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2018 | 75 | 0.310 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 14 | 0.290 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2007 | 8 | 0.280 |
Why?
|
| Obesity | 4 | 2019 | 1191 | 0.280 |
Why?
|
| Insulin Resistance | 4 | 2017 | 406 | 0.270 |
Why?
|
| Apoptosis | 6 | 2019 | 1040 | 0.270 |
Why?
|
| Mice | 23 | 2022 | 10331 | 0.260 |
Why?
|
| Mice, Knockout | 13 | 2022 | 1998 | 0.250 |
Why?
|
| Oxidative Stress | 1 | 2007 | 282 | 0.240 |
Why?
|
| Neoplasms | 2 | 2007 | 1261 | 0.240 |
Why?
|
| Animals | 25 | 2022 | 19749 | 0.230 |
Why?
|
| Gene Expression Profiling | 5 | 2017 | 712 | 0.230 |
Why?
|
| Adipose Tissue | 3 | 2017 | 284 | 0.220 |
Why?
|
| Gene Expression Regulation | 5 | 2020 | 1538 | 0.210 |
Why?
|
| Eukaryotic Cells | 1 | 2003 | 56 | 0.210 |
Why?
|
| Inflammation | 3 | 2020 | 1111 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 4 | 2011 | 64 | 0.200 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 194 | 0.190 |
Why?
|
| Phosphorylation | 7 | 2022 | 860 | 0.190 |
Why?
|
| Metabolic Syndrome | 1 | 2022 | 149 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 8 | 2019 | 3220 | 0.180 |
Why?
|
| CLOCK Proteins | 1 | 2020 | 45 | 0.180 |
Why?
|
| Phosphotyrosine | 1 | 2019 | 23 | 0.160 |
Why?
|
| Neurons | 3 | 2018 | 863 | 0.160 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2019 | 18 | 0.160 |
Why?
|
| fas Receptor | 1 | 2019 | 54 | 0.150 |
Why?
|
| Spatial Memory | 1 | 2018 | 7 | 0.150 |
Why?
|
| Neutrophils | 1 | 2020 | 352 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2019 | 651 | 0.150 |
Why?
|
| Metabolome | 1 | 2017 | 24 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2019 | 256 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2013 | 584 | 0.140 |
Why?
|
| Caloric Restriction | 1 | 2017 | 16 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2015 | 4 | 0.140 |
Why?
|
| Epigenomics | 1 | 2017 | 54 | 0.130 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 141 | 0.130 |
Why?
|
| Immunologic Memory | 1 | 2019 | 284 | 0.130 |
Why?
|
| Stress, Physiological | 2 | 2016 | 186 | 0.130 |
Why?
|
| Fibroblasts | 4 | 2011 | 370 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Somatostatin-Secreting Cells | 1 | 2015 | 8 | 0.120 |
Why?
|
| Glucagon-Secreting Cells | 1 | 2015 | 26 | 0.120 |
Why?
|
| Fetus | 1 | 2015 | 97 | 0.120 |
Why?
|
| Transcriptome | 1 | 2017 | 337 | 0.120 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 177 | 0.110 |
Why?
|
| Islets of Langerhans | 1 | 2015 | 267 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 202 | 0.100 |
Why?
|
| Cells, Cultured | 6 | 2020 | 2101 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 677 | 0.100 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2022 | 37 | 0.100 |
Why?
|
| RNA | 1 | 2015 | 405 | 0.090 |
Why?
|
| Fibroblast Growth Factors | 2 | 2022 | 63 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 630 | 0.090 |
Why?
|
| Sirtuin 1 | 1 | 2011 | 23 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 56 | 0.090 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 72 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 96 | 0.090 |
Why?
|
| Enzyme Activation | 5 | 2011 | 356 | 0.080 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2009 | 58 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2007 | 57 | 0.070 |
Why?
|
| COS Cells | 1 | 2007 | 175 | 0.070 |
Why?
|
| Lung Neoplasms | 2 | 2011 | 577 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2007 | 73 | 0.070 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2007 | 113 | 0.070 |
Why?
|
| Cerebellum | 1 | 2007 | 94 | 0.070 |
Why?
|
| Male | 9 | 2019 | 27976 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2007 | 83 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2020 | 1226 | 0.070 |
Why?
|
| Transcription Factor AP-1 | 2 | 2003 | 41 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2004 | 260 | 0.060 |
Why?
|
| Cellular Senescence | 1 | 2006 | 106 | 0.060 |
Why?
|
| Sequence Analysis, RNA | 2 | 2017 | 157 | 0.060 |
Why?
|
| Dietary Fats | 3 | 2011 | 204 | 0.060 |
Why?
|
| Muscle, Skeletal | 1 | 2010 | 678 | 0.060 |
Why?
|
| Autocrine Communication | 1 | 2004 | 31 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 73 | 0.060 |
Why?
|
| Point Mutation | 2 | 2018 | 164 | 0.060 |
Why?
|
| Cell Line | 2 | 2011 | 2018 | 0.050 |
Why?
|
| Immunity | 1 | 2004 | 97 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 161 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2006 | 388 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2004 | 742 | 0.050 |
Why?
|
| Lymphocytic choriomeningitis virus | 2 | 2019 | 86 | 0.050 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2022 | 6 | 0.050 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 74 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 472 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 98 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 1914 | 0.050 |
Why?
|
| Humans | 9 | 2020 | 60122 | 0.050 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 346 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1383 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 201 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 316 | 0.040 |
Why?
|
| Neutropenia | 1 | 2020 | 66 | 0.040 |
Why?
|
| Insulin | 2 | 2017 | 689 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 969 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 2078 | 0.040 |
Why?
|
| Glucose | 2 | 2015 | 447 | 0.040 |
Why?
|
| src-Family Kinases | 1 | 2019 | 60 | 0.040 |
Why?
|
| Arenaviridae Infections | 1 | 2019 | 14 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2004 | 766 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2018 | 5 | 0.040 |
Why?
|
| Skin Transplantation | 1 | 2019 | 155 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2019 | 171 | 0.040 |
Why?
|
| Fatty Acids | 1 | 2019 | 194 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2022 | 704 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2009 | 168 | 0.040 |
Why?
|
| Proteomics | 1 | 2019 | 264 | 0.040 |
Why?
|
| Protein Interaction Mapping | 1 | 2017 | 71 | 0.040 |
Why?
|
| Anaerobiosis | 1 | 2017 | 14 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 2020 | 371 | 0.030 |
Why?
|
| Glycolysis | 1 | 2017 | 54 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2019 | 876 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 299 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 139 | 0.030 |
Why?
|
| Agouti-Related Protein | 1 | 2016 | 4 | 0.030 |
Why?
|
| Hippocampus | 1 | 2018 | 243 | 0.030 |
Why?
|
| Homeostasis | 1 | 2019 | 343 | 0.030 |
Why?
|
| Hyperphagia | 1 | 2016 | 17 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2017 | 119 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 397 | 0.030 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2015 | 37 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 2 | 2007 | 52 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 351 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2006 | 379 | 0.030 |
Why?
|
| Cell Division | 2 | 2004 | 442 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 2 | 2003 | 35 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2004 | 309 | 0.020 |
Why?
|
| Contact Inhibition | 1 | 2011 | 3 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2011 | 16 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 88 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 63 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 107 | 0.020 |
Why?
|
| Cadherins | 1 | 2011 | 69 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 697 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1849 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 181 | 0.020 |
Why?
|
| Macrophages | 1 | 2015 | 1015 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2009 | 196 | 0.020 |
Why?
|
| Pancreas | 1 | 2009 | 146 | 0.020 |
Why?
|
| Proteome | 1 | 2009 | 142 | 0.020 |
Why?
|
| Pregnancy | 1 | 2015 | 2367 | 0.020 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 59 | 0.020 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2011 | 943 | 0.020 |
Why?
|
| Base Sequence | 1 | 2009 | 1307 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 53 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 187 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2006 | 99 | 0.020 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2006 | 61 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1580 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1973 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2006 | 594 | 0.020 |
Why?
|
| Young Adult | 1 | 2015 | 4398 | 0.020 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Receptor Cross-Talk | 1 | 2004 | 10 | 0.010 |
Why?
|
| Activin Receptors, Type I | 1 | 2004 | 14 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 28 | 0.010 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 39 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 64 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 56 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 102 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 53 | 0.010 |
Why?
|
| Homozygote | 1 | 2004 | 116 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2006 | 296 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 5959 | 0.010 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2004 | 58 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 387 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 248 | 0.010 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2003 | 10 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 44 | 0.010 |
Why?
|
| Wound Healing | 1 | 2004 | 177 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 297 | 0.010 |
Why?
|
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2002 | 9 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2002 | 24 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 42 | 0.010 |
Why?
|
| Cell Movement | 1 | 2004 | 426 | 0.010 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2002 | 26 | 0.010 |
Why?
|
| Receptors, Interleukin | 1 | 2002 | 36 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 325 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 1555 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2003 | 170 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2002 | 104 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 2002 | 125 | 0.010 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2002 | 70 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2002 | 164 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 376 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 661 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 632 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 165 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 215 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 1469 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2003 | 550 | 0.010 |
Why?
|
| Influenza A virus | 1 | 2002 | 117 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 486 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 807 | 0.010 |
Why?
|
| Mitochondria | 1 | 2002 | 337 | 0.010 |
Why?
|
| Adult | 1 | 2015 | 15989 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 16546 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2002 | 845 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2003 | 1459 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 3618 | 0.010 |
Why?
|
| Female | 1 | 2015 | 31245 | 0.010 |
Why?
|